The Recall Desk
SevereFDA (Devices)·Z-1201-2021·Announced 2021-03-17

Medtronic Recalls Valiant Navion Thoracic Stent Grafts Due to Structural Defects

Medtronic is recalling 33,430 Valiant Navion Thoracic Stent Graft Systems worldwide due to endoleaks, stent fractures, and ring enlargement.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class I, which mandates a minimum severity score of 4 per the rubric, despite the absence of reported injuries in the source text.

Plain-English summary

Medtronic Vascular, Inc. is recalling 33,430 units of the Valiant Navion Thoracic Stent Graft System. These devices are used for endovascular repair of lesions in the descending thoracic aorta. The recall covers specific model numbers and serial numbers distributed globally, including the United States and numerous international markets.

The recall was initiated due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement. These structural issues can compromise the integrity of the stent graft. The source text does not report any specific illnesses, injuries, or deaths associated with these defects.

Healthcare providers and patients should contact Medtronic Vascular, Inc. for instructions on how to manage the affected devices. The recall is classified as FDA Class I, indicating a reasonable probability that the use of the product will cause serious adverse health consequences or death.

The recalled product

Product
Valiant Navion Thoracic Stent Graft System. For endovascular repair of lesions in the descending thoracic aorta (DTA).
Affected units
33,430

Distribution

Distributed nationwide across the United States.